title: High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma.
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.forename: R
authors.initials: R
authors.lastname: Bataille
authors.forename: B
authors.initials: B
authors.lastname: Mahé
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D012008:Recurrence
chemical_list: D008558:Melphalan